APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pleural Effusions Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pleural Effusions Treatment Market Outlook and Growth Opportunities 2026

19 December 2025190 pages

Choose your research edition.

Industry ResearchPleural Effusions Treatment Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pleural Effusions Treatment Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pleural Effusions Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pleural Effusions Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pleural Effusions Treatment Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Pleural Effusions Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pleural Effusions Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pleural Effusions Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pleural Effusions Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pleural Effusions Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pleural Effusions Treatment market include Shyndec Pharmaceutical, Lepu Medical, B. Braun, Balance Medical, Smith Medical, Redax, Oakworks Medical, Nouvag and Maxer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pleural Effusions Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pleural Effusions Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pleural Effusions Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pleural Effusions Treatment market.

Pleural Effusions Treatment Segment by Company

Shyndec Pharmaceutical

Lepu Medical

B. Braun

Balance Medical

Smith Medical

Redax

Oakworks Medical

Nouvag

Maxer

Heyer Medical

Grena

Biometrix

Bicakcilar

Pleural Effusions Treatment Segment by Type

Thoracentesis

Pleurodesis

Pleuroperitoneal Shunt

Pleural Effusions Treatment Segment by Application

Hospitals

Clinics

Others

Pleural Effusions Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Pleural Effusions Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pleural Effusions Treatment key companies, revenue, market share, and recent developments.

3. To split the Pleural Effusions Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pleural Effusions Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pleural Effusions Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Pleural Effusions Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pleural Effusions Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pleural Effusions Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pleural Effusions Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pleural Effusions Treatment industry.

Chapter 3: Detailed analysis of Pleural Effusions Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pleural Effusions Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pleural Effusions Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pleural Effusions Treatment Industry Trends Table 2. Pleural Effusions Treatment Industry Drivers Table 3. Pleural Effusions Treatment Industry Opportunities and Challenges Table 4. Pleural Effusions Treatment Industry Restraints Table 5. Global Pleural Effusions Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pleural Effusions Treatment Revenue Share by Company (2021-2026) Table 7. Global Pleural Effusions Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pleural Effusions Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Pleural Effusions Treatment Company, Product Type & Application Table 10. Global Pleural Effusions Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pleural Effusions Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Thoracentesis Table 15. Significant Companies of Pleurodesis Table 16. Significant Companies of Pleuroperitoneal Shunt Table 17. Global Pleural Effusions Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pleural Effusions Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Pleural Effusions Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Pleural Effusions Treatment Sales Value Share by Type (2021-2026) Table 21. Global Pleural Effusions Treatment Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Clinics Table 24. Significant Companies of Others Table 25. Global Pleural Effusions Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pleural Effusions Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pleural Effusions Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pleural Effusions Treatment Sales Value Share by Application (2021-2026) Table 29. Global Pleural Effusions Treatment Sales Value Share by Application (2027-2032) Table 30. Global Pleural Effusions Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pleural Effusions Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pleural Effusions Treatment Sales Value Share by Region (2021-2026) Table 33. Global Pleural Effusions Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pleural Effusions Treatment Sales Value Share by Region (2027-2032) Table 35. Global Pleural Effusions Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pleural Effusions Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pleural Effusions Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Pleural Effusions Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pleural Effusions Treatment Sales Value Market Share by Country (2027-2032) Table 40. Shyndec Pharmaceutical Company Information Table 41. Shyndec Pharmaceutical Business Overview Table 42. Shyndec Pharmaceutical Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Shyndec Pharmaceutical Pleural Effusions Treatment Product Portfolio Table 44. Shyndec Pharmaceutical Recent Development Table 45. Lepu Medical Company Information Table 46. Lepu Medical Business Overview Table 47. Lepu Medical Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Lepu Medical Pleural Effusions Treatment Product Portfolio Table 49. Lepu Medical Recent Development Table 50. B. Braun Company Information Table 51. B. Braun Business Overview Table 52. B. Braun Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. B. Braun Pleural Effusions Treatment Product Portfolio Table 54. B. Braun Recent Development Table 55. Balance Medical Company Information Table 56. Balance Medical Business Overview Table 57. Balance Medical Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Balance Medical Pleural Effusions Treatment Product Portfolio Table 59. Balance Medical Recent Development Table 60. Smith Medical Company Information Table 61. Smith Medical Business Overview Table 62. Smith Medical Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Smith Medical Pleural Effusions Treatment Product Portfolio Table 64. Smith Medical Recent Development Table 65. Redax Company Information Table 66. Redax Business Overview Table 67. Redax Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Redax Pleural Effusions Treatment Product Portfolio Table 69. Redax Recent Development Table 70. Oakworks Medical Company Information Table 71. Oakworks Medical Business Overview Table 72. Oakworks Medical Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Oakworks Medical Pleural Effusions Treatment Product Portfolio Table 74. Oakworks Medical Recent Development Table 75. Nouvag Company Information Table 76. Nouvag Business Overview Table 77. Nouvag Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Nouvag Pleural Effusions Treatment Product Portfolio Table 79. Nouvag Recent Development Table 80. Maxer Company Information Table 81. Maxer Business Overview Table 82. Maxer Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Maxer Pleural Effusions Treatment Product Portfolio Table 84. Maxer Recent Development Table 85. Heyer Medical Company Information Table 86. Heyer Medical Business Overview Table 87. Heyer Medical Pleural Effusions Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Heyer Medical Pleural Effusions Treatment Product Portfolio Table 89. Heyer Medical Recent Development Table 90. Grena Company Information Table 91. Grena Business Overview Table 92. Grena Pleural Effusions Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Grena Pleural Effusions Treatment Product Portfolio Table 94. Grena Recent Development Table 95. Biometrix Company Information Table 96. Biometrix Business Overview Table 97. Biometrix Pleural Effusions Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Biometrix Pleural Effusions Treatment Product Portfolio Table 99. Biometrix Recent Development Table 100. Bicakcilar Company Information Table 101. Bicakcilar Business Overview Table 102. Bicakcilar Pleural Effusions Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Bicakcilar Pleural Effusions Treatment Product Portfolio Table 104. Bicakcilar Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Pleural Effusions Treatment Product Image Figure 2. Global Pleural Effusions Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pleural Effusions Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Pleural Effusions Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Thoracentesis Image Figure 8. Pleurodesis Image Figure 9. Pleuroperitoneal Shunt Image Figure 10. Global Pleural Effusions Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pleural Effusions Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Pleural Effusions Treatment Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Others Image Figure 16. Global Pleural Effusions Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pleural Effusions Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pleural Effusions Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Pleural Effusions Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pleural Effusions Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pleural Effusions Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pleural Effusions Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pleural Effusions Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pleural Effusions Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pleural Effusions Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pleural Effusions Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pleural Effusions Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pleural Effusions Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pleural Effusions Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pleural Effusions Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pleural Effusions Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Thoracentesis
  • Pleurodesis
  • Pleuroperitoneal Shunt
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Shyndec Pharmaceutical
  • Lepu Medical
  • B. Braun
  • Balance Medical
  • Smith Medical
  • Redax
  • Oakworks Medical
  • Nouvag
  • Maxer
  • Heyer Medical
  • Grena
  • Biometrix
  • Bicakcilar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pleural Effusions Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pleural Effusions Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pleural Effusions Treatment Market Dynamics
  1. 2.1 Pleural Effusions Treatment Industry Trends
  2. 2.2 Pleural Effusions Treatment Industry Drivers
  3. 2.3 Pleural Effusions Treatment Industry Opportunities and Challenges
  4. 2.4 Pleural Effusions Treatment Industry Restraints
3 Pleural Effusions Treatment Market by Company
  1. 3.1 Global Pleural Effusions Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Pleural Effusions Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Pleural Effusions Treatment Company Ranking (2024-2026)
  4. 3.4 Global Pleural Effusions Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Pleural Effusions Treatment Company Product Type and Application
  6. 3.6 Global Pleural Effusions Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pleural Effusions Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pleural Effusions Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pleural Effusions Treatment Market by Type
  1. 4.1 Pleural Effusions Treatment Type Introduction
  2. 4.1.1 Thoracentesis
  3. 4.1.2 Pleurodesis
  4. 4.1.3 Pleuroperitoneal Shunt
  5. 4.2 Global Pleural Effusions Treatment Sales Value by Type
  6. 4.2.1 Global Pleural Effusions Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pleural Effusions Treatment Sales Value by Type (2021-2032)
  8. 4.2.3 Global Pleural Effusions Treatment Sales Value Share by Type (2021-2032)
5 Pleural Effusions Treatment Market by Application
  1. 5.1 Pleural Effusions Treatment Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Pleural Effusions Treatment Sales Value by Application
  6. 5.2.1 Global Pleural Effusions Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pleural Effusions Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pleural Effusions Treatment Sales Value Share by Application (2021-2032)
6 Pleural Effusions Treatment Regional Value Analysis
  1. 6.1 Global Pleural Effusions Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pleural Effusions Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pleural Effusions Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pleural Effusions Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pleural Effusions Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Pleural Effusions Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pleural Effusions Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Pleural Effusions Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pleural Effusions Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pleural Effusions Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pleural Effusions Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Pleural Effusions Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pleural Effusions Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pleural Effusions Treatment Sales Value Share by Country, 2025 VS 2032
7 Pleural Effusions Treatment Country-level Value Analysis
  1. 7.1 Global Pleural Effusions Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pleural Effusions Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pleural Effusions Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pleural Effusions Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pleural Effusions Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pleural Effusions Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pleural Effusions Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shyndec Pharmaceutical
  2. 8.1.1 Shyndec Pharmaceutical Company Information
  3. 8.1.2 Shyndec Pharmaceutical Business Overview
  4. 8.1.3 Shyndec Pharmaceutical Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shyndec Pharmaceutical Pleural Effusions Treatment Product Portfolio
  6. 8.1.5 Shyndec Pharmaceutical Recent Developments
  7. 8.2 Lepu Medical
  8. 8.2.1 Lepu Medical Company Information
  9. 8.2.2 Lepu Medical Business Overview
  10. 8.2.3 Lepu Medical Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lepu Medical Pleural Effusions Treatment Product Portfolio
  12. 8.2.5 Lepu Medical Recent Developments
  13. 8.3 B. Braun
  14. 8.3.1 B. Braun Company Information
  15. 8.3.2 B. Braun Business Overview
  16. 8.3.3 B. Braun Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 B. Braun Pleural Effusions Treatment Product Portfolio
  18. 8.3.5 B. Braun Recent Developments
  19. 8.4 Balance Medical
  20. 8.4.1 Balance Medical Company Information
  21. 8.4.2 Balance Medical Business Overview
  22. 8.4.3 Balance Medical Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Balance Medical Pleural Effusions Treatment Product Portfolio
  24. 8.4.5 Balance Medical Recent Developments
  25. 8.5 Smith Medical
  26. 8.5.1 Smith Medical Company Information
  27. 8.5.2 Smith Medical Business Overview
  28. 8.5.3 Smith Medical Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Smith Medical Pleural Effusions Treatment Product Portfolio
  30. 8.5.5 Smith Medical Recent Developments
  31. 8.6 Redax
  32. 8.6.1 Redax Company Information
  33. 8.6.2 Redax Business Overview
  34. 8.6.3 Redax Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Redax Pleural Effusions Treatment Product Portfolio
  36. 8.6.5 Redax Recent Developments
  37. 8.7 Oakworks Medical
  38. 8.7.1 Oakworks Medical Company Information
  39. 8.7.2 Oakworks Medical Business Overview
  40. 8.7.3 Oakworks Medical Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Oakworks Medical Pleural Effusions Treatment Product Portfolio
  42. 8.7.5 Oakworks Medical Recent Developments
  43. 8.8 Nouvag
  44. 8.8.1 Nouvag Company Information
  45. 8.8.2 Nouvag Business Overview
  46. 8.8.3 Nouvag Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nouvag Pleural Effusions Treatment Product Portfolio
  48. 8.8.5 Nouvag Recent Developments
  49. 8.9 Maxer
  50. 8.9.1 Maxer Company Information
  51. 8.9.2 Maxer Business Overview
  52. 8.9.3 Maxer Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Maxer Pleural Effusions Treatment Product Portfolio
  54. 8.9.5 Maxer Recent Developments
  55. 8.10 Heyer Medical
  56. 8.10.1 Heyer Medical Company Information
  57. 8.10.2 Heyer Medical Business Overview
  58. 8.10.3 Heyer Medical Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Heyer Medical Pleural Effusions Treatment Product Portfolio
  60. 8.10.5 Heyer Medical Recent Developments
  61. 8.11 Grena
  62. 8.11.1 Grena Company Information
  63. 8.11.2 Grena Business Overview
  64. 8.11.3 Grena Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Grena Pleural Effusions Treatment Product Portfolio
  66. 8.11.5 Grena Recent Developments
  67. 8.12 Biometrix
  68. 8.12.1 Biometrix Company Information
  69. 8.12.2 Biometrix Business Overview
  70. 8.12.3 Biometrix Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biometrix Pleural Effusions Treatment Product Portfolio
  72. 8.12.5 Biometrix Recent Developments
  73. 8.13 Bicakcilar
  74. 8.13.1 Bicakcilar Company Information
  75. 8.13.2 Bicakcilar Business Overview
  76. 8.13.3 Bicakcilar Pleural Effusions Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bicakcilar Pleural Effusions Treatment Product Portfolio
  78. 8.13.5 Bicakcilar Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst